Rochon PA, Gurwitz JH. Drug therapy. Lancet. 1995;346(8966):32–6.
Article CAS PubMed Google Scholar
Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM. “Kind of blurry”: deciphering clues to prevent, investigate and manage prescribing cascades. PLoS ONE. 2022;17(8): e0272418.
Article CAS PubMed PubMed Central Google Scholar
Brath H, Mehta N, Savage RD, Gill SS, Wu W, Bronskill SE, et al. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018;66(11):2079–85.
Kalisch LM, Caughey GE, Roughead EE, Gilbert AL. The prescribing cascade. Aust Prescr. 2011;34(6):162–6.
McCarthy LM, Visentin JD, Rochon PA. Assessing the scope and appropriateness of prescribing cascades. J Am Geriatr Soc. 2019;67(5):1023–6.
Nunnari P, Ceccarelli G, Ladiana N, Notaro P. Prescribing cascades and medications most frequently involved in pain therapy: a review. Eur Rev Med Pharm Sci. 2021;25(2):1034–41.
Morris EJ, Hollmann J, Hofer AK, Bhagwandass H, Oueini R, Adkins LE, et al. Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: a scoping review. Res Social Adm Pharm. 2022;18(7):3079–93.
Doherty AS, Shahid F, Moriarty F, Boland F, Clyne B, Dreischulte T, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharm Res Perspect. 2022;10(5): e01008.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Article PubMed PubMed Central Google Scholar
O Adrien AM, Hugtenburg JG, McCarthy L, Priester-Vink S, Visscher R, van den Bemt PMLA, et al. Prescribing cascades: a systematic review. PROSPERO 2021 CRD42021253004. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021253004. Accessed 27 Sep 2023.
Koster J. PubMed PubReMiner 2023. https://hgserver2.amc.nl/cgi-bin/miner/miner2.cgi. Accessed 27 Sep 2023.
Ovid Embase. 2023. https://tools.ovid.com/embase/. Accessed 27 Sep 2023.
Nursing - Literature Reviews & Systematic Reviews. Backward & Forward Reference Searching. Florida Atlantic University; 2023 [updated 03-03-2023]. https://libguides.fau.edu/c.php?g=966176&p=7013756. Accessed 27 Sep 2023.
MEB 27: MEB commentary on the Guideline on Summary of Product Characteristics, 23 August 2017. https://www.cbg-meb.nl/documenten/beleidsdocumenten/2023/01/01/meb-27. Accessed 27 Sep 2023.
NHG. NHG richtlijnen. https://richtlijnen.nhg.org/. Accessed 27 Sep 2023.
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994;55(1):76–83.
Article CAS PubMed Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2023 2023 [updated 01-23-2023]. https://www.whocc.no/atc_ddd_index/. Accessed 27 Sep 2023.
Agency EM. Summary of product characteristics 2023. https://www.ema.europa.eu/en/glossary/summary-product-characteristics. Accessed 30 Apr 2023.
US Food and Drug Administration (FDA). Index drug specific information 2023 [updated 28-02-2023]. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/index-drug-specific-information. Accessed 30 Feb 2023.
Whetzel PL NN, Shah NH, Alexander PR, Nyulas C, Tudorache T, Musen MA. Medical Dictionary for Regulatory Activities terminology (MedDRA). Nucleic Acids Res. https://bioportal.bioontology.org/ontologies/MEDDRA. Accessed 27 Sep 2023.
Avorn J, Gurwitz JH, Bohn RL, Mogun H, Monane M, Walker A. Increased incidence of levodopa therapy following metoclopramide use. JAMA. 1995;274(22):1780–2.
Article CAS PubMed Google Scholar
Huh Y, Kim DH, Choi M, Park JH, Kwon DY, Jung JH, et al. Metoclopramide and levosulpiride use and subsequent levodopa prescription in the Korean elderly: the prescribing cascade. J Clin Med. 2019;8(9):1496.
Article CAS PubMed PubMed Central Google Scholar
Janetzki JL, Sykes MJ, Ward MB, Pratt NL. Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease: a sequence symmetry analysis approach. J Clin Pharm Ther. 2021;46(6):1687–94.
Article CAS PubMed Google Scholar
Hashimoto M, Hashimoto K, Ando F, Kimura Y, Nagase K, Arai K. Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis. J Pharm Health Care Sci. 2015;1:7.
Article PubMed PubMed Central Google Scholar
Caughey GE, Roughead EE, Pratt N, Shakib S, Vitry AI, Gilbert AL. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf. 2010;19(9):977–82.
Vegter S, de Jong-van den Berg LT. Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough. Br J Clin Pharmacol. 2010;69(2):200–3.
Chen Y, Huang ST, Hsu TC, Peng LN, Hsiao FY, Chen LK. Detecting suspected prescribing cascades by prescription sequence symmetry analysis of nationwide real-world data. J Am Med Dir Assoc. 2022;23(3):468–74.
Vegter S, de Boer P, van Dijk KW, Visser S, de Jong-van den Berg LT. The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis. Drug Saf. 2013;36(6):435–9.
Bowman L, Carlstedt BC, Miller ME, McDonald CJ. Evaluation of ACE-inhibitor (ACE-I) associated cough using modified prescription sequence analysis (PSA). Pharmacoepidemiol Drug Saf. 1995;4(1):17–22.
Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997;50(8):953–9.
Article CAS PubMed Google Scholar
Zhang H, Wu J, Zhang Z, Qian H, Wang Y, Yang M, et al. Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis. Ther Clin Risk Manage. 2019;15:803–10.
Nishtala PS, Chyou TY. Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions. J Clin Pharm Ther. 2017;42(2):189–94.
Article CAS PubMed Google Scholar
Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG. Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol Drug Saf. 2002;11(7):601–6.
Article CAS PubMed Google Scholar
Pratt N, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, et al. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015;24(8):858–64.
Article PubMed PubMed Central Google Scholar
Yokoyama S, Tanaka Y, Hosomi K, Takada M. Polypharmacy is associated with amiodarone-induced hypothyroidism. Int J Med Sci. 2021;18(15):3574–80.
Article CAS PubMed PubMed Central Google Scholar
Garrison SR, Dormuth CR, Morrow RL, Carney GA, Khan KM. Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. Arch Intern Med. 2012;172(2):120–6.
Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, et al. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med. 2020;180(5):643–51.
Article CAS PubMed PubMed Central Google Scholar
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, et al. Identifying prescribing cascades in Alzheimer’s disease and related dementias: the calcium channel blocker-diuretic prescribing cascade. Pharmacoepidemiol Drug Saf. 2021;30(8):1066–73.
Vouri SM, van Tuyl JS, Olsen MA, Xian H, Schootman M. An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade. J Am Pharm Assoc (2003). 2018;58(5):534–9.e4.
Vouri SM, Jiang X, Manini TM, Solberg LM, Pepine C, Malone DC, et al. Magnitude of and characteristics associated with the treatment of calcium channel blocker-induced lower-extremity edema with loop diuretics. JAMA Netw Open. 2019;2(12): e1918425.
Article PubMed PubMed Central Google Scholar
Trenaman SC, Bowles SK, Kirkland S, Andrew MK. An examination of three prescribing cascades in a cohort of older adults with dementia. BMC Geriatr. 2021;21(1):297.
Article PubMed PubMed Central Google Scholar
Kalisch Ellett LM, Pratt NL, Barratt JD, Rowett D, Roughead EE. Risk of medication-associated initiation of oxybutynin in elderly men and women. J Am Geriatr Soc. 2014;62(4):690–5.
Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med. 1990;150(11):2286–90.
Article CAS PubMed Google Scholar
Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986;255(3):357–60.
Article CAS PubMed Google Scholar
Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7(5):478–84.
Article CAS PubMed Google Scholar
Johnell K, Fastbom J. The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol. 2008;64(11):1119–24.
van Dijk KN, de Vries CS, van den Berg PB, Dijkema AM, Brouwers JR, de Jong-van den Berg LT. Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. Br J Clin Pharmacol. 1998;46(3):255–61.
Pouwels KB, Visser ST, Bos HJ, Hak E. Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis. Drug Saf. 2013;36(11):1079–86.
Article CAS PubMed Google Scholar
Sturkenboom MC, Middelbeek A, de Jong van den Berg LT, van den Berg PB, Stricker BH, Wesseling H. Vulvo-vaginal candidiasis associated with acitretin. J Clin Epidemiol. 1995;48(8):991–7.
Monane M, Avorn J, Beers MH, Everitt DE. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med. 1993;153(5):633–8.
Comments (0)